Search in:

Advanced search

Drug Design, Development and Therapy Volume 9, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

Pei-Jian Peng1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China

Bao-Jun Lv2 Department of Surgical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China

Con Tang2 Department of Surgical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China

Hai Liao3 Department of Medical Oncology, Cancer Centre, Sun Yat-sen University, Guangzhou, People’s Republic of China

Zhong Lin1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China

Yu-Meng Liu4 Department of Oncology, People’s Hospital of Zhongshan City, Zhongshan, People’s Republic of China

Zhi-Hui Wang1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, People’s Republic of China

Si-Yang Wang5 Department of Radiation Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, People’s Republic of China

Zhi-Bin Cheng5 Department of Radiation Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong Province, People’s Republic of ChinaCorrespondence[email protected]

show all

Pages 6401-6405 | Published online: 10 Dec 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

ChangETAdamiHOThe enigmatic epidemiology of nasopharyngeal carcinomaCancer Epidemiol Biomarkers Prey2006151017651777
PubMed Web of Science ®Google Scholar
CaoSMSimonsMJQianCNThe prevalence and prevention of nasopharyngeal carcinoma in ChinaChin J Cancer20113011411921272443
PubMedGoogle Scholar
ZhangLChenQYLiuHTangLQMaiHQEmerging treatment options for nasopharyngeal carcinomaDrug Des Devel Ther201373752
PubMed Web of Science ®Google Scholar
LeeAWNgWTChanYHSzeHChanCLamTHThe battle against nasopharyngeal cancerRadiother Oncol2012104327227822938727
PubMed Web of Science ®Google Scholar
MaBBChanATRecent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinomaCancer20051031223115565580
PubMed Web of Science ®Google Scholar
LeeAWSzeWMAuJSTreatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experienceInt J Radiat Oncol Biol Phys20056141107111615752890
PubMed Web of Science ®Google Scholar
SuárezCRodrigoJPRinaldoALangendijkJAShahaARFerlitoACurrent treatment options for recurrent nasopharyngeal cancerEur Arch Otorhinolaryngol2010267121811182420865269
PubMed Web of Science ®Google Scholar
NgeowJLimWTLeongSSDocetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinomaAnn Oncol201122371872220716628
PubMed Web of Science ®Google Scholar
ChuaDTShamJSAuGKA phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinomaOral Oncol200541658959515975521
PubMed Web of Science ®Google Scholar
SasakiYShinkaiTEguchiKPrediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassayCancer Chemother Pharmacol19912742632701847845
PubMed Web of Science ®Google Scholar
KawaiYTaniuchiSOkaharaSNakamuraMGembaMRelationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulationBiol Pharm Bull20052881385138816079479
PubMed Web of Science ®Google Scholar
AlbertsDSFantaPTRunningKLIn vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human ovarian cancersCancer Chemother Pharmacol19973964934979118460
PubMed Web of Science ®Google Scholar
PengPJOuXQChenZBMulticenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapyCancer Chemother Pharmacol201372232332823728706
PubMed Web of Science ®Google Scholar
KuritaHYamamotoENozakiSWadaSFurutaIKurashinaKMulticenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinomaOral Oncol200440101000100615509491
PubMed Web of Science ®Google Scholar
SimonROptimal two-stage designs for phase II clinical trialsControl Clin Trials19891011102702835
PubMedGoogle Scholar
MaBBHuiEPChanATSystemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directionsCancer Sci20089971311131818498420
PubMed Web of Science ®Google Scholar
AuEAngPTA phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinomaAnn Oncol19945187898172799
PubMed Web of Science ®Google Scholar
NganRKYiuHHLauWHCombination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II studyAnn Oncol20021381252125812181249
PubMed Web of Science ®Google Scholar
LiYHWangFHJiangWQPhase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinomaCancer Chemother Pharmacol200862353954418172651
PubMed Web of Science ®Google Scholar
YeoWLeungTWTChanATCA phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinomaEur J Cancer199834132027203110070305
PubMed Web of Science ®Google Scholar
ZhangLZhangYHuangPYXuFPengPJGuanZZPhase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapyCancer Chemother Pharmacol2008611333817909810
PubMed Web of Science ®Google Scholar
WangCCChangJYLiuTWLinCYYuYCHongRLPhase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinomaHead Neck2006281748016331692
PubMed Web of Science ®Google Scholar
HuiEPMaBBLeungSFRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaJ Clin Oncol200927224224919064973
PubMed Web of Science ®Google Scholar
SasakiYTamuraTEguchiKPharmacokinetics of (glycolate-0,0′)-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatinCancer Chemother Pharmacol19892342432462647312
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date